Drug-labels.com

Taro-Terconazole: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
0.4 %
Active ingredient:
Similar drugs:

Patient Medication Information: uses, side effects, how to take - Taro-Terconazole

ABOUT THIS MEDICATION

What the medication is used for:

TARO-TERCONAZOLE Vaginal Cream is used for the local treatment of yeast infections caused by an organism called candidiasis (moniliasis).

What it does:

TARO-TERCONAZOLE is a synthetic antifungal agent which is active against various strains of Candida albicans by interfering with the fungal cell membrane to stop growth of the fungus and help stop the infection.

When it should not be used:

You should not take TARO-TERCONAZOLE if you are allergic to terconazole, or to any of the non-medicinal ingredients in the product (see What the non-medicinal ingredients are).

What the medicinal ingredient is:

Terconazole

What the nonmedicinal ingredients are:

TARO-TERCONAZOLE: butylated hydroxyanisole, propylene glycol, purified water, polysorbate 80, isopropyl myristate, cetyl alcohol, stearyl alcohol, polysorbate 60.

What dosage forms it comes in:

TARO-TERCONAZOLE 0.4% Vaginal Cream

W

WARNING AND PRECAUTIONS

ARNINGS AND PRECAUTIONS

BEFORE you use TARO-TERCONAZOLE talk to your doctor or pharmacist if:

  • you are pregnant, or think you may be; This

    medication should not be used in the first trimester of pregnancy.

  • you are breast-feeding or planning to breastfeed;
  • you are a diabetic.

For topical use on the vulva and inside the vagina only.

TARO-TERCONAZOLE is not for ophthalmic or oral use.

Stop TARO-TERCONAZOLE use and contact your doctor immediately if irritation, fever, chills or flu-like symptoms occur.

INTERACTIONS WITH THIS MEDICATION

INTERACTIONS WITH THIS MEDICATION

TARO-TERCONAZOLE is not affected by oral contraceptive usage.

PROPER USE OF THIS MEDICATION

PROPER USE OF THIS MEDICATION

Usual Adult Dose:

One applicatorful (5 g) of TARO-TERCONAZOLE vaginal cream is administered intravaginally once daily at bedtime for seven consecutive days. In addition, a thin layer of TARO-TERCONAZOLE vaginal cream (0.4% terconazole) is applied for 7 consecutive days directly to the vulva and massaged in gently.

Directions for using the vaginal applicator

Filling the applicator: Remove cap from tube. Reverse cap to puncture seal. Screw applicator to tube. Squeeze tube from the bottom until applicator plunger is fully extended – then remove applicator from tube.

Hold the filled applicator by the cylinder and gently insert it into the vagina as far as it will go comfortably.

Press plunger and deposit the cream. While keeping plunger depressed, remove the applicator from the vagina.

Complete the prescribed course of treatment to reduce the chance of re-infection.

Avoid tight-fitting undergarments, pants, pantyhose, etc.

Overdose:

In the event of oral ingestion of vaginal cream, your doctor will provide supportive and symptomatic measures should be carried out. If the cream is accidentally applied to the eyes, wash with clean water or saline and seek medical attention if symptoms persist.

If you think you, or a person you are caring for, have taken too much Taro-Terconazole contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

FECTS AND WHAT TO DO

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Along with its intended action, any medication may cause unwanted effects. Some of the side effects that have been reported include:

  • headache
  • burning
  • pain
  • itching
  • irritation
  • allergic reaction, sometimes severe
  • rash
  • fever
  • chills

Be alert to the following serious side effects which are possible for those using TARO-TERCONAZOLE

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

REPORTING SIDE EFFECTS

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

HOW TO STORE IT

TARO-TERCONAZOLE vaginal cream should be stored at room temperature (15ºC to 30 ºC).

Keep out of the reach and sight of children.

MORE INFORMATION

If you want more information about Taro-Terconazole:

  • Talk to your healthcare professional

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Very Rare

Severe allergic reaction with symptoms such as

swollen face, lips, mouth,

tongue or throat; difficulty

swallowing or breathing;

√
life-threatening rash with blisters and peeling skin√
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html; the manufacturer’s website: http://www.taro.ca; or by calling 1-800-268-1975.

130 East Drive,

Brampton, Ontario L6T 1C1

TARO is a registered trademark of Taro Pharmaceuticals Inc.

Last revised: December 23, 2021

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02247651

Revision date stated in the text: December 23, 2021

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Taro-Terconazole

Rx or OTC
Prescription (Rx)?
DIN 02247651
Schedule(s) PRESCRIPTION
Active ingredient(s) Terconazole 0.4 %
Dosage form(s) Cream
Route(s) of administration Vaginal
Drug class (WHO ATC)
  1. G Genito urinary system and sex hormones
    1. G01 Gynecological antiinfectives and antiseptics
      1. G01A Antiinfectives and antiseptics, excl. combinations with corticosteroids
        1. G01AG Triazole derivatives, gynecological antiinfectives and antiseptics
          1. G01AG02 Terconazole
Company TARO PHARMACEUTICALS INC
Current status Marketed
Current status date September 21, 2004

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.